Synovus Financial Corp Dexcom Inc Transaction History

Synovus Financial Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $296,648 - $475,444	-3,447 Reduced 16.33%	17,663 $1.65 Million
Q2 2023 Aug 08, 2023	SELL	$112.47 - $130.98 $101,785 - $118,536	-905 Reduced 4.11%	21,110 $2.71 Million
Q1 2023 May 11, 2023	BUY	$104.0 - $122.92 $2.29 Million - $2.71 Million	22,015 New	22,015 $2.56 Million
Q2 2021 Aug 11, 2021	SELL	$80.99 - $107.93 $127,883 - $170,421	-1,579 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$84.79 - $104.74 $13,396 - $16,548	158 Added 11.12%	1,579 $564,000
Q4 2020 Feb 11, 2021	BUY	$78.0 - $104.5 $3,120 - $4,180	40 Added 2.9%	1,421 $520,000
Q3 2020 Nov 09, 2020	BUY	$95.51 - $112.95 $53,103 - $62,800	556 Added 67.39%	1,381 $569,000
Q2 2020 Aug 10, 2020	BUY	$62.68 - $105.34 $14,291 - $24,017	228 Added 38.19%	825 $335,000
Q1 2020 Apr 24, 2020	BUY	$47.79 - $75.63 $27,861 - $44,092	583 Added 4164.29%	597 $162,000
Q4 2019 Feb 06, 2020	BUY	$36.62 - $57.29 $512 - $802	14 New	14 $3,000
Q2 2019 Aug 08, 2019	SELL	$27.84 - $38.92 $334 - $467	-12 Closed	0 $0
Q4 2018 Feb 07, 2019	SELL	$26.99 - $37.37 $9,500 - $13,154	-352 Reduced 96.7%	12 $1,000
Q1 2018 May 07, 2018	BUY	$13.06 - $18.54 $4,753 - $6,748	364 New	364 $27,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Synovus Financial Corp with notifications on news.